ESOPHAGEAL OBSTRUCTION - rEMERGs
ESOPHAGEAL OBSTRUCTION - rEMERGs
ESOPHAGEAL OBSTRUCTION - rEMERGs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
- occurs in 10% of pts w/ GERD<br />
- 10% of pts w/ barrett’s esoph have coexistent adenoCa at time of dx<br />
- 40Xs risk of Ca than general population<br />
- should be followed w/ endoscopy and bx<br />
Differential dx<br />
‣ Cardiac ischemia is the main ddx<br />
‣ Note that GERD pain can radiate similar to ischemia<br />
‣ Radiation to abdomen is 3Xs more commonn in GERD than ischemia<br />
‣ Exacerbation of symptoms after meals (fullness sensation) is more suggestive of GERD<br />
‣ Worse with swallowing suggests GERD<br />
‣ Relief by antacids does NOT r/o cardiac<br />
Treatment<br />
‣ Does NOT target H. pylori (not related to GERD)<br />
‣ PHASE I<br />
- lifestyle, dietary, elevate bed, avoid factors which dec LES tone, wt lo<br />
loss, stop smoking, review drugs, avoid night time eating, dietary review,<br />
frequent small meals, symptomatic antacids<br />
‣<br />
‣<br />
‣<br />
PHASE II<br />
- H2 antagonist<br />
‣ cimetidine (tagamet) 300mg bid<br />
‣ ranitidine (zantac) 150mg bid<br />
‣ famotidine (pepcid)40mg od<br />
‣ nizantidine (axid) 150mg bid<br />
- prokinetics<br />
‣<br />
PHASE III<br />
- PPIs<br />
‣<br />
‣<br />
‣<br />
PHASE IV<br />
- sugery (fundal plication)<br />
cisapride (prepulsid) 20mg bid - qid (inc LES tone, and inc<br />
gastric emptying)<br />
omeprazole (losec) 20mg od<br />
lanoprazole (prevasid) 30mg od<br />
pantoprazole (pantoloc) 40mg od